MYND Life Sciences Inc. (CSE:MYND)
0.0300
-0.0500 (-62.50%)
Mar 26, 2025, 5:06 PM EST
MYND Life Sciences Statistics
Total Valuation
CSE:MYND has a market cap or net worth of CAD 1.55 million. The enterprise value is 4.55 million.
Market Cap | 1.55M |
Enterprise Value | 4.55M |
Important Dates
The next estimated earnings date is Thursday, April 3, 2025.
Earnings Date | Apr 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:MYND has 51.82 million shares outstanding. The number of shares has decreased by -0.92% in one year.
Current Share Class | n/a |
Shares Outstanding | 51.82M |
Shares Change (YoY) | -0.92% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.39 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
Current Ratio | 0.09 |
Quick Ratio | 0.09 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.47 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -151.46% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 21.47% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 1.55 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.08 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 19.31 |
Average Volume (20 Days) | 3,779 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:MYND had revenue of CAD 1 and -542,565 in losses. Loss per share was -0.01.
Revenue | 1 |
Gross Profit | -331,778 |
Operating Income | -1.29M |
Pretax Income | -542,565 |
Net Income | -542,565 |
EBITDA | -1.28M |
EBIT | -1.29M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 497 in cash and 3.00 million in debt, giving a net cash position of -3.00 million or -0.06 per share.
Cash & Cash Equivalents | 497 |
Total Debt | 3.00M |
Net Cash | -3.00M |
Net Cash Per Share | -0.06 |
Equity (Book Value) | -5.99M |
Book Value Per Share | -0.13 |
Working Capital | -6.09M |
Cash Flow
Operating Cash Flow | -172,775 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -128,598,000.00% |
Pretax Margin | -54,256,500.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:MYND does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.92% |
Shareholder Yield | 0.92% |
Earnings Yield | -34.90% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CSE:MYND has an Altman Z-Score of -36.38. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -36.38 |
Piotroski F-Score | n/a |